Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Chugai Pharmaceutical
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed as having RA, on the basis of the criteria stipulated by the American Conference on Rheumatism(ACR) in 1987
Active RA despite at least one DMARDs or immunosuppressants or Infliximab or Etanercept.Active disease is defined as having at least 6 tender and 6 swollen joints among DAS28 (Modified Disease Activity Scores that include twenty eight joint counts) and ESR at least 30 mm/hr or CRP not less than 2.0mg/dL
Active RA despite over 10mg adrenocortical steroids within 2 weeks before entry of this study
You may not be if
Shown to have class-Ⅳ Steinbrocker's functional activity in an evaluation carried out within 4 weeks before administration of the study drug
Treated with Infliximab within 3 months before and with Etanercept within 2 weeks before administration of the study drug
Subjected to any of the following within 4 weeks before administration of the study drug:
